We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-2.2%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$53.7B
AUM Growth
-$2.95B
(-5.2%)
Cap. Flow
+$168M
Cap. Flow
% of AUM
0.31%
Top 10 Holdings %
Top 10 Hldgs %
35.03%
Holding
1,742
New
57
Increased
475
Reduced
481
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$234M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$120M |
| 3 |
Micron Technology
MU
|
+$114M |
| 4 |
CoStar Group
CSGP
|
+$112M |
| 5 |
Linde
LIN
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTAI Aviation
FTAI
|
+$421M |
| 2 |
AbbVie
ABBV
|
+$174M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$126M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$107M |
| 5 |
Capital One
COF
|
+$84.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.44% |
| 2 | Financials | 12.06% |
| 3 | Healthcare | 11.81% |
| 4 | Communication Services | 9.87% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Becton Dickinson
BDX
$42.1B
| $5.16M | 0.01% |
32,822
+3,313
| +11% | +$608K |
|
527
Leidos
LDOS
$13.4B
| $5.16M | 0.01% |
33,176
+5,493
| +20% | +$986K |
|
528
Arthur J. Gallagher & Co
AJG
$62.3B
| $5.15M | 0.01% |
23,767
-37,261
| -61% | -$8.61M |
|
529
Assurant
AIZ
$13.5B
| $5.07M | 0.01% |
23,286
+18,580
| +395% | +$4.24M |
|
530
Omega Healthcare
OHI
$15B
| $5.02M | 0.01% |
114,649
+80,269
| +233% | +$3.66M |
|
531
American Healthcare REIT
AHR
$11B
| $5M | 0.01% |
106,007
+32,949
| +45% | +$1.63M |
|
532
Diamondback Energy
FANG
$57.3B
| $4.93M | 0.01% |
24,930
+9,488
| +61% | +$1.61M |
|
533
F5
FFIV
$22.6B
| $4.91M | 0.01% |
16,985
-20,598
| -55% | -$5.71M |
|
|
PVLA
534
Palvella Therapeutics
PVLA
$2.04B
| $4.89M | 0.01% |
+39,223
| New | +$4.09M |
|
|
SNDK
535
Sandisk
SNDK
$239B
| $4.89M | 0.01% |
7,689
+350
| +5% | +$198K |
|
536
Trex
TREX
$4.45B
| $4.87M | 0.01% |
133,716
+71,724
| +116% | +$2.89M |
|
537
NewMarket
NEU
$7.04B
| $4.86M | 0.01% |
7,588
+1,389
| +22% | +$901K |
|
538
Paychex
PAYX
$39.3B
| $4.86M | 0.01% |
52,741
-38,397
| -42% | -$3.8M |
|
539
Crown Holdings
CCK
$13B
| $4.83M | 0.01% |
48,181
-205,249
| -81% | -$21.9M |
|
|
SOLS
540
Solstice Advanced Materials
SOLS
$9.64B
| $4.81M | 0.01% |
63,100
-2,419
| -4% | -$166K |
|
541
Expeditors International
EXPD
$23.3B
| $4.8M | 0.01% |
33,511
+10,611
| +46% | +$1.61M |
|
542
Omnicom Group
OMC
$22.6B
| $4.79M | 0.01% |
63,665
+21,586
| +51% | +$1.67M |
|
543
Vera Therapeutics
VERA
$2.63B
| $4.77M | 0.01% |
118,675
+116,075
| +4,464% | +$5M |
|
544
Rocket Lab Corp
RKLB
$43.7B
| $4.73M | 0.01% |
73,651
+26,101
| +55% | +$1.97M |
|
545
APA Corp
APA
$12.8B
| $4.72M | 0.01% |
111,120
-289,002
| -72% | -$8.74M |
|
546
Ameriprise Financial
AMP
$47.4B
| $4.72M | 0.01% |
10,611
+2,400
| +29% | +$1.16M |
|
547
Deckers Outdoor
DECK
$14.2B
| $4.7M | 0.01% |
46,941
+15,248
| +48% | +$1.63M |
|
548
Vanguard FTSE Emerging Markets ETF
VWO
$121B
| $4.7M | 0.01% |
86,918
| – | – |
|
549
Oneok
OKE
$58B
| $4.68M | 0.01% |
51,767
-19,999
| -28% | -$1.65M |
|
550
GE HealthCare
GEHC
$28B
| $4.68M | 0.01% |
65,682
+12,470
| +23% | +$983K |
|
Similar funds
SCP
Ensign Peak Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Ensign Peak Advisors held 1,742 positions worth $53.7B, down 5.2% from $56.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Ensign Peak Advisors's Q1 2026 filing shows 57 new, 475 increased, 481 reduced and 34 closed positions. Its largest new stake was Novo Nordisk: 400,384 shares worth $14.7M. The largest sale was FTAI Aviation, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.
- Ensign Peak Advisors's largest Q1 2026 buy was Novo Nordisk: 400,384 shares worth $14.7M.
- Ensign Peak Advisors added most to Boston Scientific in Q1 2026, an estimated $234M increase.
- Ensign Peak Advisors's biggest Q1 2026 reduction was FTAI Aviation, cutting an estimated $421M.
- Ensign Peak Advisors fully exited Exact Sciences in Q1 2026, selling an estimated $17M.
- Ensign Peak Advisors's ten largest holdings make up 35% of its $53.7B portfolio in Q1 2026.
- Ensign Peak Advisors opened 57 new positions and closed 34 in Q1 2026.
- Ensign Peak Advisors's portfolio value fell 5.2% quarter-over-quarter to $53.7B.
Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.